- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00661843
A Study of Yoga for Treating Geriatric Insomnia
A Mixed Design, With Wait List Control Crossover to Intervention, Clinical Trial of Integrated Yoga Style Practice Intervention for Improving Sleep and Quality of Life in the Elderly Population
Study Overview
Status
Intervention / Treatment
Detailed Description
Introduction: Geriatric insomnia is prevalent, reducing life quality, diminishing cognition and increasing risk of accidents and mortality. Treatment with sedative-hypnotic drugs has limited effectiveness and further increases the risk of accidents and falls. Yoga has been shown to increase well-being in the elderly.
Hypotheses
- Integrated yoga style practice can improve sleep quality/quantity
- Integrated yoga style practice can improve quality of life.
Objectives:
- Examine effectiveness of yoga for insomnia and reduction in use of hypnotics/relaxants in the elderly;
- Determine whether yoga enhances quality of life in the elderly; and 3. Determine whether yoga is suitable for elderly in western culture(s).
Methods:
A mixed design crossover controlled trial (n =74, age range 60-87, M = 74.4, SD = 7.1) with 2 weekly classes incorporating physical and meditative yoga, and daily home practice of meditative yoga for 12 weeks. Measures included self-reported assessment of sleep quality (Sleep Logs, KSS, ESS, PSQI, MAPS), mood states (DASS, POMS), general health (SF-36) and mobile objective home sleep studies.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Jerusalem, Israel, 91031
- Shaare Zedek Medical Center, Sleep Lab
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 60 years or older
- Independent, self mobile
- Suffering from light to severe primary insomnia
Exclusion Criteria:
- Age less than 60 years
- Currently or in the past engaged in regular yoga practice
- Suffering from any physical or mental health condition or disability which may affect sleep, or for which Yoga practice is counter indicated or may lead to health risks or complications.
- Suffering from co-morbid insomnia in conjunction with another condition clearly salient to sleep disturbance.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: 1
Intervention group: Intervention constitutes of 2 supervised yoga classes per week incorporating gentle Yoga postures, relaxation and meditation sequences In addition: daily home based sessions of yogic relaxation and meditation using a pre-recorded audio CD
|
Intervention constitutes of 2 supervised yoga style classes per week incorporating gentle postures,relaxation and meditation sequences.
In addition daily home based sessions of yogic relaxation, and meditation a an audio CD
|
|
NO_INTERVENTION: 2
Control in waiting to be crossed over after control phase completed.
Participants of this group studied using same objective and subjective outcome measures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective sleep and life quality assessment using standard questionnaires and sleep logs
Time Frame: 24 weeks
|
all measures taken at baseline and post intervention for all participants participant who crossed over measured pre and post control phase and post intervention phase
|
24 weeks
|
|
Objective home based sleep studies using
Time Frame: 24 weeks
|
objective sleep studies using embletta mobile sleep recording system in conjunction with the HPC1000 sleep analysis system. all measures taken pre and post intervention. Participants who crossed over measured pre control, post control and post intervention phases |
24 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Anda Baharav, MD, Shaare Zedek Medical Center
- Study Chair: Jonathan Halpern, M.Sc., Royal Melbourne Institue of Technology University
- Principal Investigator: Clement Cahan, MD, Shaare Zedek Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SZMCSL0001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.